| Adverse effects of biologics used for treating IBD A Stallmach, S Hagel, T Bruns Best practice & research Clinical gastroenterology 24 (2), 167-182, 2010 | 256 | 2010 |
| Quantifying the Hawthorne effect in hand hygiene compliance through comparing direct observation with automated hand hygiene monitoring S Hagel, J Reischke, M Kesselmeier, J Winning, P Gastmeier, ... infection control & hospital epidemiology 36 (8), 957-962, 2015 | 246 | 2015 |
| Infectious disease consultation for Staphylococcus aureus bacteremia–a systematic review and meta-analysis M Vogel, RPH Schmitz, S Hagel, MW Pletz, N Gagelmann, A Scherag, ... Journal of Infection 72 (1), 19-28, 2016 | 230 | 2016 |
| Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011 A Dignass, JC Preiß, DE Aust, F Autschbach, A Ballauff, G Barretton, ... Zeitschrift fur Gastroenterologie 49 (9), 1276-1341, 2011 | 187 | 2011 |
| The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European … AJ Stewardson, A Allignol, J Beyersmann, N Graves, M Schumacher, ... Eurosurveillance 21 (33), 30319, 2016 | 183 | 2016 |
| Prevalence and etiology of community-acquired pneumonia in immunocompromised patients MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ... Clinical Infectious Diseases 68 (9), 1482-1493, 2019 | 153 | 2019 |
| Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ... The Lancet Infectious diseases 16 (12), 1364-1376, 2016 | 139 | 2016 |
| Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011–Ergebnisse einer Evidenzbasierten Konsensuskonferenz A Dignass, JC Preiß, DE Aust, F Autschbach, A Ballauff, G Barretton, ... Zeitschrift für Gastroenterologie, 1276-1341, 2011 | 128 | 2011 |
| External ventricular drain infections: risk factors and outcome S Hagel, T Bruns, MW Pletz, C Engel, R Kalff, C Ewald Interdisciplinary perspectives on infectious diseases 2014, 2014 | 119 | 2014 |
| Extra length of stay and costs because of health care–associated infections at a German university hospital H Arefian, S Hagel, S Heublein, F Rissner, A Scherag, FM Brunkhorst, ... American journal of infection control 44 (2), 160-166, 2016 | 111 | 2016 |
| Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial S Hagel, F Bach, T Brenner, H Bracht, A Brinkmann, T Annecke, A Hohn, ... Intensive Care Medicine 48 (3), 311-321, 2022 | 106 | 2022 |
| Three dimensional checkerboard synergy analysis of colistin, meropenem, tigecycline against multidrug-resistant clinical Klebsiella pneumonia isolates C Stein, O Makarewicz, JA Bohnert, Y Pfeifer, M Kesselmeier, S Hagel, ... PloS one 10 (6), e0126479, 2015 | 106 | 2015 |
| Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia S Weis, M Kesselmeier, JS Davis, AM Morris, S Lee, A Scherag, S Hagel, ... Clinical Microbiology and Infection 25 (7), 818-827, 2019 | 98 | 2019 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 81 | 2023 |
| Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial M Diab, T Lehmann, W Bothe, P Akhyari, S Platzer, D Wendt, AC Deppe, ... Circulation 145 (13), 959-968, 2022 | 79 | 2022 |
| Identification of bacterial DNA in neutrocytic and non‐neutrocytic cirrhotic ascites by means of a multiplex polymerase chain reaction T Bruns, S Sachse, E Straube, S Assefa, A Herrmann, S Hagel, ... Liver International 29 (8), 1206-1214, 2009 | 77 | 2009 |
| Medical and surgical therapy of inflammatory bowel disease in the elderly—prospects and complications A Stallmach, S Hagel, A Gharbi, U Settmacher, M Hartmann, C Schmidt, ... Journal of Crohn's and Colitis 5 (3), 177-188, 2011 | 75 | 2011 |
| S2k-leitlinie gastrointestinale infektionen und morbus Whipple S Hagel, HJ Epple, GE Feurle, WV Kern, PL Jansen, P Malfertheiner, ... Zeitschrift für Gastroenterologie 53 (05), 418-459, 2015 | 70 | 2015 |
| Quality of blood culture testing-a survey in intensive care units and microbiological laboratories across four European countries RPH Schmitz, PM Keller, M Baier, S Hagel, MW Pletz, FM Brunkhorst Critical care 17, 1-9, 2013 | 63 | 2013 |
| Isavuconazole shortens the QTc interval SC Mellinghoff, M Bassetti, D Dörfel, S Hagel, N Lehners, A Plis, E Schalk, ... Mycoses 61 (4), 256-260, 2018 | 61 | 2018 |
Mathias PletzJena University HospitalVerified email at med.uni-jena.de
